Cresco Labs (CRLBF) Receivables - Other (2019 - 2022)

Cresco Labs (CRLBF) posted Receivables - Other of $1.0 million for Q1 2022, up 400.0% on a QoQ basis from $200000.0 in Q4 2020.

Cresco Labs (CRLBF) Receivables - Other (2019 - 2022) Analysis & Trends

Cresco Labs' Receivables - Other history runs 3 years deep, the most recent figure standing at $1.0 million for Q1 2022.

  • Quarterly Receivables - Other changed N/A year-over-year to $1.0 million in Q1 2022, while the trailing twelve-month figure through Dec 2020 was $200000.0 (down 100.0% YoY) and the FY2022 annual result came in at $300000.0, changed N/A from the prior year.
  • Receivables - Other was $1.0 million for Q1 2022 at Cresco Labs, up from $200000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $11.3 billion in Q4 2019 and bottomed at $200000.0 in Q4 2020.
  • A 3-year average of $3.8 billion and a median of $1.0 million in 2022 frame the typical range for Receivables - Other.
  • Peak annual rise in Receivables - Other reached 100.0% in 2020, while the deepest fall reached 100.0% in 2020.
  • Cresco Labs' Receivables - Other stood at $11.3 billion in 2019, then tumbled by 100.0% to $200000.0 in 2020, then surged by 400.0% to $1.0 million in 2022.
  • Business Quant data shows CRLBF's Receivables - Other at $1.0 million in Q1 2022, $200000.0 in Q4 2020, and $11.3 billion in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Cresco Labs 254.96 Mn 99.57 Mn 75.45 Mn

Historic Data

Download Data
DateValue
Mar 31, 2022 1.00 Mn
Mar 31, 2022 1.00 Mn
Dec 31, 2020 200,000.00
Dec 31, 2020 200,000.00
Dec 31, 2019 11.33 Bn
Dec 31, 2019 11.33 Bn